Abstract
Gene therapy emerged as important approach in treatment for many inborn disorders caused by genetic defects, as well as other diseases. This manuscript focused on Adeno-associated virus (AAV) based gene therapy to eye diseases. The paper firstly introduced the AAV vectors and the techniques of eye delivery, then summarized some tested genes that were used in past treatment to retinal degeneration disorders. Finally the paper discussed the updated optogenetics and its roles in AAV based gene therapy for eye diseases.
Similar content being viewed by others
References
Acland GM, Aguirre GD, Ray J, Zhang Q, Aleman TS et al (2001) Gene therapy restores vision in a canine model of childhood blindness. Nat Genet 28:92–95
Acland GM, Aguirre GD, Bennett J, Aleman TS, Cideciyan AV et al (2005) Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness. Mol Ther 12:1072–1082
Ali RR, Sarra GM, Stephens C, Alwis MD, Bainbridge JW et al (2000) Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy. Nat Genet 25:306–310
Apte RS, Barreiro RA, Duh E, Volpert O, Ferguson TA (2004) Stimulation of neovascularization by the anti-angiogenic factor PEDF. Invest Ophthalmol Vis Sci 45:4491–4497
Arrenberg AB, Stainier DY, Baier H, Huisken J (2010) Optogenetic control of cardiac function. Science 330:971–974
Barnstable CJ, Tombran-Tink J (2004) Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential. Prog Retin Eye Res 23:561–577
Bi A, Cui J, Ma YP, Olshevskaya E, Pu M et al (2006) Ectopic expression of a microbial-type rhodopsin restores visual responses in mice with photoreceptor degeneration. Neuron 50:23–33
Bok D (2004) Gene therapy of retinal dystrophies: achievements, challenges and prospects. Novartis Found Symp 255:4–12 discussion -6, 177–8
Bok D, Yasumura D, Matthes MT, Ruiz A, Duncan JL et al (2002) Effects of adeno-associated virus-vectored ciliary neurotrophic factor on retinal structure and function in mice with a P216L rds/peripherin mutation. Exp Eye Res 74:719–735
Busskamp V, Duebel J, Balya D, Fradot M, Viney TJ et al (2010) Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa. Science 329:413–417
Chong NV, Adewoyin T (2007) Intravitreal injection: balancing the risks. Eye (Lond) 21:313–316
da Cruz L, Rakoczy P, Constable I (1997) Ocular gene therapy: the basic science and current state of research. Aust N Z J Ophthalmol 25:97–104
Dejneka NS, Rex TS, Bennett J (2003) Gene therapy and animal models for retinal disease. Dev Ophthalmol 37:188–198
Deng WT, Yan Z, Dinculescu A, Pang J, Teusner JT et al (2005) Adeno-associated virus-mediated expression of vascular endothelial growth factor peptides inhibits retinal neovascularization in a mouse model of oxygen-induced retinopathy. Hum Gene Ther 16:1247–1254
Dinculescu A, Glushakova L, Min SH, Hauswirth WW (2005) Adeno-associated virus-vectored gene therapy for retinal disease. Hum Gene Ther 16:649–663
Drenser KA, Timmers AM, Hauswirth WW, Lewin AS (1998) Ribozyme-targeted destruction of RNA associated with autosomal-dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci 39:681–689
Ek ET, Dass CR, Choong PF (2006) Pigment epithelium-derived factor: a multimodal tumor inhibitor. Mol Cancer Ther 5:1641–1646
Eriksson K, Magnusson P, Dixelius J, Claesson-Welsh L, Cross MJ (2003) Angiostatin and endostatin inhibit endothelial cell migration in response to FGF and VEGF without interfering with specific intracellular signal transduction pathways. FEBS Lett 536:19–24
Ernst OP, Sanchez Murcia PA, Daldrop P, Tsunoda SP, Kateriya S, Hegemann P (2008) Photoactivation of channelrhodopsin. J Biol Chem 283:1637–1643
Farah N, Reutsky I, Shoham S (2007) Patterned optical activation of retinal ganglion cells. Conf Proc IEEE Eng Med Biol Soc 2007:6369–6371
Fiala A, Suska A, Schluter OM (2010) Optogenetic approaches in neuroscience. Curr Biol 20:R897–R903
Friedmann T, Roblin R (1972) Gene therapy for human genetic disease? Science 175:949–955
Green ES, Rendahl KG, Zhou S, Ladner M, Coyne M et al (2001) Two animal models of retinal degeneration are rescued by recombinant adeno-associated virus-mediated production of FGF-5 and FGF-18. Mol Ther 3:507–515
Hauswirth WW, Li Q, Raisler B, Timmers AM, Berns KI et al (2004) Range of retinal diseases potentially treatable by AAV-vectored gene therapy. Novartis Found Symp 255:179–188 discussion 88–94
Ivanova E, Pan ZH (2009) Evaluation of the adeno-associated virus mediated long-term expression of channelrhodopsin-2 in the mouse retina. Mol Vis 15:1680–1689
Ivanova E, Hwang GS, Pan ZH, Troilo D (2010) Evaluation of AAV-mediated expression of Chop2-GFP in the marmoset retina. Invest Ophthalmol Vis Sci 51:5288–5296
Jacobson SG, Cideciyan AV (2010) Treatment possibilities for retinitis pigmentosa. N Engl J Med 363:1669–1671
Janovjak H, Szobota S, Wyart C, Trauner D, Isacoff EY (2010) A light-gated, potassium-selective glutamate receptor for the optical inhibition of neuronal firing. Nat Neurosci 13:1027–1032
Jia H, Jezequel S, Lohr M, Shaikh S, Davis D et al (2001) Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF. Biochem Biophys Res Commun 283:164–173
Knopfel T, Lin MZ, Levskaya A, Tian L, Lin JY, Boyden ES (2010) Toward the second generation of optogenetic tools. J Neurosci 30:14998–15004
Lagali PS, Balya D, Awatramani GB, Munch TA, Kim DS et al (2008) Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration. Nat Neurosci 11:667–675
Lai YK, Shen WY, Brankov M, Lai CM, Constable IJ, Rakoczy PE (2002) Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy. Gene Ther 9:804–813
Lau D, McGee LH, Zhou S, Rendahl KG, Manning WC et al (2000) Retinal degeneration is slowed in transgenic rats by AAV-mediated delivery of FGF-2. Invest Ophthalmol Vis Sci 41:3622–3633
LaVail MM, Yasumura D, Matthes MT, Drenser KA, Flannery JG et al (2000) Ribozyme rescue of photoreceptor cells in P23H transgenic rats: long-term survival and late-stage therapy. Proc Natl Acad Sci USA 97:11488–11493
Lewin AS, Drenser KA, Hauswirth WW, Nishikawa S, Yasumura D et al (1998) Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa. Nat Med 4:967–971
Liang FQ, Aleman TS, Dejneka NS, Dudus L, Fisher KJ et al (2001) Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa. Mol Ther 4:461–472
Lin B, Koizumi A, Tanaka N, Panda S, Masland RH (2008) Restoration of visual function in retinal degeneration mice by ectopic expression of melanopsin. Proc Natl Acad Sci USA 105:16009–16014
Liu X, Tonegawa S (2010) Optogenetics 3.0. Cell 141:22–24
Mata NL, Moghrabi WN, Lee JS, Bui TV, Radu RA et al (2004) Rpe65 is a retinyl ester binding protein that presents insoluble substrate to the isomerase in retinal pigment epithelial cells. J Biol Chem 279:635–643
McGee Sanftner LH, Abel H, Hauswirth WW, Flannery JG (2001) Glial cell line derived neurotrophic factor delays photoreceptor degeneration in a transgenic rat model of retinitis pigmentosa. Mol Ther 4:622–629
Miller G (2006) Optogenetics. Shining new light on neural circuits. Science 314:1674–1676
Murata T, Kimura H, Sakamoto T, Osusky R, Spee C et al (1997) Ocular gene therapy: experimental studies and clinical possibilities. Ophthalmic Res 29:242–251
Narfstrom K, Katz ML, Bragadottir R, Seeliger M, Boulanger A et al (2003a) Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog. Invest Ophthalmol Vis Sci 44:1663–1672
Narfstrom K, Katz ML, Ford M, Redmond TM, Rakoczy E, Bragadottir R (2003b) In vivo gene therapy in young and adult RPE65-/- dogs produces long-term visual improvement. J Hered 94:31–37
Sampat KM, Garg SJ (2010) Complications of intravitreal injections. Curr Opin Ophthalmol 21:178–183
Sarra GM, Stephens C, de Alwis M, Bainbridge JW, Smith AJ et al (2001) Gene replacement therapy in the retinal degeneration slow (rds) mouse: the effect on retinal degeneration following partial transduction of the retina. Hum Mol Genet 10:2353–2361
Schlichtenbrede FC, da Cruz L, Stephens C, Smith AJ, Georgiadis A et al (2003a) Long-term evaluation of retinal function in Prph2Rd2/Rd2 mice following AAV-mediated gene replacement therapy. J Gene Med 5:757–764
Schlichtenbrede FC, MacNeil A, Bainbridge JW, Tschernutter M, Thrasher AJ et al (2003b) Intraocular gene delivery of ciliary neurotrophic factor results in significant loss of retinal function in normal mice and in the Prph2Rd2/Rd2 model of retinal degeneration. Gene Ther 10:523–527
Smith AJ, Schlichtenbrede FC, Tschernutter M, Bainbridge JW, Thrasher AJ, Ali RR (2003) AAV-Mediated gene transfer slows photoreceptor loss in the RCS rat model of retinitis pigmentosa. Mol Ther 8:188–195
Thyagarajan S, van Wyk M, Lehmann K, Lowel S, Feng G, Wassle H (2010) Visual function in mice with photoreceptor degeneration and transgenic expression of channelrhodopsin 2 in ganglion cells. J Neurosci 30:8745–8758
Tomita H, Sugano E, Isago H, Hiroi T, Wang Z et al (2010) Channelrhodopsin-2 gene transduced into retinal ganglion cells restores functional vision in genetically blind rats. Exp Eye Res 90:429–436
Tong JP, Yao YF (2006) Contribution of VEGF and PEDF to choroidal angiogenesis: a need for balanced expressions. Clin Biochem 39:267–276
Tsao YP, Ho TC, Chen SL, Cheng HC (2006) Pigment epithelium-derived factor inhibits oxidative stress-induced cell death by activation of extracellular signal-regulated kinases in cultured retinal pigment epithelial cells. Life Sci 79:545–550
Wei L (2005) Adenovector pigment epithelium-derived factor (AdPEDF) delivery for wet age-related macular degeneration. Retina 25:S48–S49
Wright AF (1997) Gene therapy for the eye. Br J Ophthalmol 81:620–623
Yabe T, Sanagi T, Yamada H (2010) The neuroprotective role of PEDF: implication for the therapy of neurological disorders. Curr Mol Med 10:259–266
Zhang Y, Ivanova E, Bi A, Pan ZH (2009) Ectopic expression of multiple microbial rhodopsins restores ON and OFF light responses in retinas with photoreceptor degeneration. J Neurosci 29:9186–9196
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, S., Liu, P., Song, L. et al. Adeno-associated virus (AAV) based gene therapy for eye diseases. Cell Tissue Bank 12, 105–110 (2011). https://doi.org/10.1007/s10561-011-9243-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10561-011-9243-7